Delivery Order SPE2DB24D9238-SPE2DB25FDRAP
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,137.60 contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product XOLAIR 150 MG/ML SYRINGE. The contract has a potential value of $14,700.32 and a completion date of March 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that supplies a wide range of branded and generic pharmaceuticals to U.S. government agencies,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of XOLAIR 150 MG/ML syringes. The total ceiling value of the order is $77,370.00, with an ultimate completion date of September 23, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,605.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through August 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,284.40 firm fixed-price contract is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,642.20 contract is for the delivery of XOLAIR 150 MG/ML syringes by April 29, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24FR8ES with DLA, valued up to $4,999,999 through 2025, for the provision of a broad range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of XOLAIR 150 MG/ML SYRINGEML. This $38,685 contract has an ultimate completion date of May 8, 2024 and is not associated with a set-aside program. DMS Pharmaceutical Group is a pharmaceutical wholesaler based in Park Ridge, Illinois that supplies a wide range of branded and generic prescription drugs, over-the-counter medications,...
- The U.S. government agency, the Defense Logistics Agency (DLA), awarded a $1,547.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a period of performance through September 25, 2024, and is for the provision of the pharmaceutical product Xolair 150 mg/mL syringe. This delivery order is placed under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of Xolair 150 mg/1.2 ml powder vials. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, carries no set-aside designation and will be performed in Park Ridge, Illinois, where the vendor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $38,685.00, is for the supply of the pharmaceutical product Xolair 150 mg/ml syringe. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows DLA...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDRAPDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,284.40 to DMS Pharmaceutical Group Inc. for XOLAIR 150 mg/ml syringes, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was issued on September 9, 2025, without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. The company has been registered in SAM.gov since 2001 and specializes in providing comprehensive pharmaceutical products and medical supplies to federal healthcare systems, particularly the Department of Defense. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a significant single-award vehicle valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for an extensive range of pharmaceutical products supporting medical supply needs across military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent contract performance, with a robust portfolio of delivery orders covering prescription medications, biologics, vaccines, and specialty pharmaceutical products across various therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/9/25 |